Predictors of VT recurrence in patients with VT inducibility at
the end of radiofrequency ablation: Should we use VT non-inducibility as
a routine endpoint?
Kazutaka
Nakasone1, MD,
Koji Fukuzawa*1, 2, MD, PhD, Kunihiko
Kiuchi1, 2, MD, PhD, Mitsuru
Takami1, MD, PhD, Jun Sakai1, MD,
Toshihiro Nakamura1, MD, Atsusuke
Yatomi1, MD, Yusuke Sonoda1, MD,
Hiroyuki Takahara1, MD, Kyoko
Yamamoto1, MD, Yuya Suzuki1, MD,
Kenichi Tani1, MD, Hidehiro Iwai1,
MD, Yusuke Nakanishi1, MD, Ken-ichi
Hirata1, MD, PhD
1 Division of Cardiovascular Medicine, Department of Internal Medicine,
Kobe University Graduate School of Medicine, Kobe, Japan
2 Section of Arrhythmia, Division of Cardiovascular Medicine, Department
of Internal Medicine, Kobe University Graduate School of Medicine, Kobe,
Japan
*Corresponding Author